Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Experimental Eye Research|November 25, 2021
Inhibition of ocular neovascularization by novel anti-angiogenic compoundDavid Gau, Lucile Vignaud, Paul Francoeur, et al.
The Journal of Biological Chemistry|May 24, 2020
Disruption of profilin1 function suppresses developmental and pathological retinal neovascularizationDavid Gau, Lucile Vignaud, Abigail Allen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 7, 2020
Antagonist of nucleolin, N6L, inhibits neovascularization in mouse models of retinopathiesMarie Darche, Mélissande Cossutta, Laure Caruana, et al.
Journal of Neuroinflammation|March 18, 2018
Chronic exposure to tumor necrosis factor alpha induces retinal pigment epithelium cell dedifferentiationSara Touhami, Fanny Beguier, Sébastien Augustin, et al.
Investigative Ophthalmology & Visual Science|February 13, 2020
Rescue of Defective Electroretinographic Responses in Dp71-Null Mice With AAV-Mediated Reexpression of Dp71Mirella Telles Salgueiro Barboni, Cyrille Vaillend, Anneka Joachimsthaler, et al.
Glia|March 8, 2021
Reproducing diabetic retinopathy features using newly developed human induced-pluripotent stem cell-derived retinal Müller glial cellsAude Couturier, Guillaume Blot, Lucile Vignaud, et al.
Animal Models and Experimental Medicine|January 17, 2020
Characterization of two rat models of cystic fibrosis-KO and F508del CFTR-Generated by Crispr-Cas9Elise Dreano, Marc Bacchetta, Juliette Simonin, et al.
Journal of Neuroinflammation|January 5, 2020
IL-1β induces rod degeneration through the disruption of retinal glutamate homeostasisHugo Charles-Messance, Guillaume Blot, Aude Couturier, et al.
The Journal of Clinical Investigation|October 2, 2023
Perilipin 2-positive mononuclear phagocytes accumulate in the diabetic retina and promote PPARγ-dependent vasodegenerationGuillaume Blot, Rémi Karadayi, Lauriane Przegralek, et al.
The Journal of Clinical Endocrinology and Metabolism|October 8, 2019
Glucagon-like Peptide 1 Receptor Agonists, Diabetic Retinopathy and Angiogenesis: The AngioSafe Type 2 Diabetes StudyBénédicte Gaborit, Jean-Baptiste Julla, Samaher Besbes, et al.
Pageof 1